Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

被引：0
|
作者：
Mikihiro Kusama
Tadashi Nomizu
Kenjiro Aogi
Masataka Yoshimoto
Noboru Horikoshi
Toshio Tabei
Shinzaburo Noguchi
Shigeto Miura
Norio Yoshimura
Morihiko Kimura
Kazushige Toyama
Eisei Shin
机构：
[1] Tokyo Medical University,
[2] Hoshi General Hospital,undefined
[3] National Hospital Shikoku Cancer Center,undefined
[4] Cancer Institute Hospital,undefined
[5] Japanese Foundation for Cancer Research,undefined
[6] Saitama Prefectural Cancer Center,undefined
[7] Osaka University,undefined
[8] Aichi Prefecture Cancer Center,undefined
[9] Kyoto Prefectural University,undefined
[10] Gunma Prefecture Cancer Center,undefined
[11] Shizuoka Prefecture General Hospital,undefined
[12] National Osaka Hospital,undefined
[13] Sinjyuku Breast Center Kusama Clinic,undefined
[14] International University of Health and Welfare,undefined
[15] Mita Hospital,undefined
[16] Juntendo University School of Medicine,undefined
[17] Kamiiida Daiichi General Hospital,undefined
[18] Ohta General Hospital,undefined
[19] Shizuoka Health Management Center,undefined
[20] Iseikai Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Capecitabine; Breast cancer; Advanced; Metastatic; Efficacy; Safety; Four-week (Japanese) regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 240
页数：7
相关论文
共 50 条
  • [11] Phase II study of weekly docetaxel in patients with metastatic breast cancer
    Aihara, T
    Kim, Y
    Takatsuka, Y
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 286 - 292
  • [12] Weekly paclitaxel in metastatic breast cancer patients: A phase II study
    Gori, S
    Mosconi, AM
    Basurto, C
    Cherubini, R
    De Angelis, V
    Tonato, M
    Colozza, M
    TUMORI, 2002, 88 (06) : 470 - 473
  • [13] Treosulphan monotherapy for metastatic breast cancer - A phase II study.
    Dobson, LS
    Clive, S
    Dawson, L
    Anderson, A
    Leonard, RCF
    Kunkler, I
    Coleman, RE
    BRITISH JOURNAL OF CANCER, 1998, 78 : 42 - 42
  • [14] A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer
    Lortholary, Alain
    Hardy-Bessard, Anne-Claire
    Bachelot, Thomas
    de Rauglaudre, Gaeetan
    Alexandre, Jerome
    Bourgeois, Hugues
    Jaubert, Dominique
    Paraiso, Desire
    Largillier, Remy
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (01) : 127 - 135
  • [15] Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: A phase II report of the SAKK
    Gick, Ute
    Rochlitz, Christoph
    Mingrone, Walter
    Pestalozzi, Bernhard
    Rauch, Daniel
    Ballabeni, Pierluigi
    Lanz, Doris
    Hess, Viviane
    Aebi, Stefan
    ONCOLOGY, 2006, 71 (1-2) : 54 - 60
  • [16] A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer
    Alain Lortholary
    Anne-Claire Hardy-Bessard
    Thomas Bachelot
    Gaëtan de Rauglaudre
    Jérôme Alexandre
    Hugues Bourgeois
    Dominique Jaubert
    Désiré Paraiso
    Rémy Largillier
    Breast Cancer Research and Treatment, 2012, 131 : 127 - 135
  • [17] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390
  • [18] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Zhang, Pin
    Tong, Zhongsheng
    Tian, Fuguo
    Wang, Yongsheng
    Yang, Junlan
    Li, Weilian
    Di, Lijun
    Liu, Wei
    Tang, Li
    Qiu, Rongguo
    Xu, Binghe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [19] Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer
    Cartwright, TH
    Cohn, A
    Varkey, JA
    Chen, YM
    Szatrowski, TP
    Cox, JV
    Schulz, JJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 160 - 164
  • [20] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Pin Zhang
    Zhongsheng Tong
    Fuguo Tian
    Yongsheng Wang
    Junlan Yang
    Weilian Li
    Lijun Di
    Wei Liu
    Li Tang
    Rongguo Qiu
    Binghe Xu
    Journal of Hematology & Oncology, 9
12345